MétaCan
Menu
Back to cohort

Multivitamins After Myocardial Infarction in Patients With Diabetes

2025· article· en· W4408091481 on OpenAlexaffabout
Francisco Ujueta, Gervasio A. Lamas, Kevin J. Anstrom, Ana Navas‐Acién, Robin Boineau, Yves Rosenberg, Mario Stylianou, Teresa L.Z. Jones, Bonnie R. Joubert, Qilu Yu, Jun Wen, Hayley Nemeth, Zhen Huang, Vivian Fonseca, David M. Nathan, Gabriel I. Uwaifo, Ivan A. Arenas, Lan Luo, Jeffrey Baker, Diana Visentin, André Paixão, John F. Schmedtje, Daniel B. Mark, Philip Bear, Donna Prouty, Jodi Baxter, Jonathan K. Ehrman, Heather Golden, Vikrant Katoch, Raffi K. Krikorian, Fujiko Anazawa, Leybi Ramirez-Kelly, Abby Nolen, Venus Barney, Gerald Natzke, Rodica Pop‐Busui, Cindy Plunkett, Laura Meyer, J. Kirk Roberts, Scott A. Rollins, Tamra Hollis, Nampalli Vijay, Melinda Washam, David Zidar, Terence Semenec, Lauren Huntington, Amanda Klumpp, Matthew S. Doughty, Joseph P. Allen, Rebecca Cortez, Bhaskar Purushottam, Kirstin Stauffacher, Kelly J. Airey, Elena Christofides, Jordyn Conway, David Hoffman, Patty Schuler, Ronald M Solbrig, Loni Chacon, Phillip D. Levy, Linda Gojcevic, R. Eric Collins, John Miles McClure, Ellen Mook, Christopher R. deFilippi, Wendy Sheaffer, Antoinette Bonaccorso, Daniel Donovan, Julee Hartwell, Andrew P. Garner, Dawn Kalbfliesh, David H. Hsi, Maryanne Ducey, Paula Trump, Urs A. Leuenberger, Katie Loffredo, Betty Persico, Allan Magaziner, Dennis Goodman, Michela L. Garabedian, J. Coates, Jeanne P. Wingo, Sheldon H. Gottlieb, Michael Schächter, Sally Minniefield, Olakunle Akinboboye, Kazi Masel Ullah, Karen Wolske, Dennis Friedman, Daniel Lorber, M. Tsovian, Regina Druz, Patricia Hodnett, Stephanie Meller, Maria B. Bartolome, Giselle Cortez Vargas, Ian Ergui, Priscilla Valls, Marnie Lozada, Raul R. Blanco, Esteban Escolar, Xiaoou Pan, Ilana Seidel, Melisa Corado-Williams, Ana Lamas, Mariana Viera-Navarro, Miguel Á. Treviño, Kimberly Mai, Rachel S. Eidelman, Gabriela Reyes, Kelly Brown, Ricardo Yaryura, Amy Little, Heber Varela, Malu Bienes, Robert Jeanfreau, Paul Neff, Mark S. Thompson, Melody Lineberger-Moore, Donna Miller, Rakesh Prashad, John Schmedtje, Melissa M. Shelton, Charles B. Treasure, Ashley Freel, Gerardo Rojas, Damaris Bruceles, Veronica Hixon- Calliet, Amber Passini, Stacey Melton, Denise Moreno, Antonio Blanco, Anisia Otero, Mayra Rodriguez, Felix Sogade, Simisola O. Oludare, Cynthia Moreau, Sofia Marquez, Phillip A. Duncan, Unice Davis, Steven Tang, Bonnie DeMuth, D. Christie, Lorin Roberts, Amanda Martin, Summer Waddle, Shameka Brown, Salvatore Lo Bianco, Helmut O. Steinberg, Amy Bell, Dharmendra Patel, Alison Bailey, Michelle C. Rice, David Herrington, Karen Blinson, Lynda Doomy, David Smith, Jenny Norton, Suvi Gross, Assad Mouhaffel, Clinton Guillory, Samantha Korn, Y. Wady Aude, Yirsa Esparza, Sonia Leal, Leidy Abreu, Eric Auerbach, Cindy Huff, Miriam Brooks, Marina Johnson, Tammy D. Allen, Arthur J. Berkson, Krystal McAuliffe, Holly Little, Raymond Little, Jalal Abbas, Christina Collard, Jamie Foreman, Shelby Richardson, Andre Desire, Ayham Shneker, Omar Cordero, Piotr Kunik, Radoslav Kiesz, K. Sasser, Patrick Golden, Renee Garden, Allen Green, Gordon Fung, Keith Uyemura, Sajad Hamal, Matthew J. Budoff, Dinh Dinh, Jenny Nguyen, Ashwini Erande, Kelly Brink, Shaista Malik, Nicolas Chronos, Nicole Maslanka, Philip O'Donnell, Margaret Ann Bittorf, Rajesh Garg, Della Matheson, Walter Herbert Haught, Lisa Eskridge, Naseem Jaffrani, Melissa Trimble, James Powell, Winifred Bryant, Nakeydia Bryant, Shmuel Bergman, Rezelle Libuit, Angelica Bringas, Lori Murphy, Adrienne Junek, Shadi Nahas, Joseph Berlingieri, Caroline Urso, Alireza Moshiri, T.S.J. Elliott, Marla Inducil, Wanda Parker, Ryan Stults, Hwasoon Kim, Beatriz Acevedo, Nancy J. LoIacono

Bibliographic record

VenueJAMA Internal Medicine · 2025
Typearticle
Languageen
FieldMedicine
TopicFolate and B Vitamins Research
Canadian institutionsBarrie Urology Group
Fundersnot available
KeywordsMedicinePlaceboMyocardial infarctionClinical endpointInternal medicineDiabetes mellitusRandomized controlled trialAdverse effectStroke (engine)Surgery

Abstract

fetched live from OpenAlex

Importance: In 2013, the Trial to Assess Chelation Therapy (TACT) reported that in 1708 patients with stable coronary disease and prior myocardial infarction (MI), oral multivitamins and multiminerals (OMVMs), in a factorial design with edetate disodium (EDTA) chelation therapy, did not reduce cardiovascular events relative to placebo OMVMs, but active EDTA combined with active OMVMs was superior to placebo OMVM/placebo EDTA. Objective: To compare OMVM vs placebo in terms of efficacy for reducing major adverse cardiovascular events in patients with diabetes and prior MI. Design, Setting, and Participants: The TACT2 randomized, multicenter double-masked 2 × 2 factorial clinical trial took place across 88 sites in the US and Canada. Participants were 50 years or older, had diabetes, and had an MI 6 weeks ago or more. TACT2 participants were enrolled between September 2016 and December 2020. Data were collected between October 2016 and June 2023. Interventions: Six caplets daily of a 28 component OMVM or matching OMVM placebo, and 40 weekly infusions of an EDTA-based chelation solution or matching placebo, in a 1:1:1:1 allocation ratio. Main Outcomes and Measures: The primary end point was the composite of all-cause mortality, MI, stroke, coronary revascularization, or hospitalization for unstable angina. Results: A total of 1000 participants were randomized (500 in the active OMVM group and 500 in the placebo group). The median (IQR) age was 67 (60-72) years, and 730 (73%) were male. Median (IQR) follow-up was 48 (34-58) months. The primary end point occurred in 175 participants (35%) in the active OMVM group and 175 (35%) in the placebo group (hazard ratio [HR], 0.99 [95% CI, 0.80-1.22]; P = .92). The 5-year event rate for the primary end point in the EDTA chelation + active OMVM group was 34.0%; in the EDTA chelation + placebo OMVM group, 35.7%; in the placebo infusion + active OMVM group, 36.0%; and in the placebo infusion + placebo OMVM group, 34.3%. The comparison of the active infusion + active OMVM with the placebo infusion + placebo OMVM was not significant (HR, 0.91 [95% CI, 0.67-1.23]; P = .54). Although nonsignificant, there was a numerically higher event rate of MI, stroke, mortality from cardiovascular causes in the active OMVM compared to placebo OMVM group. Conclusions and Relevance: The results of this randomized clinical trial demonstrated that, for participants with chronic coronary disease, diabetes, and a previous MI, high-dose OMVM alone or in conjunction with EDTA-based chelation did not reduce cardiovascular events. Trial Registration: ClinicalTrials.gov Identifier: NCT02733185.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.029
Threshold uncertainty score0.402

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.005
GPT teacher head0.266
Teacher spread0.261 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJAMA Internal MedicineSame topicFolate and B Vitamins ResearchFrench-language works237,207